{"id":40134,"date":"2026-10-27T09:06:36","date_gmt":"2026-10-27T09:06:36","guid":{"rendered":"https:\/\/dev.accevo.com\/blog\/pharma-mes-integration-connecting-erp-lims-scada-and-equipment\/"},"modified":"2026-10-27T09:06:48","modified_gmt":"2026-10-27T09:06:48","slug":"pharma-mes-integration-erp-lims-scada","status":"publish","type":"post","link":"https:\/\/accevo.com\/pl\/blog\/pharma-mes-integration-erp-lims-scada\/","title":{"rendered":"Pharma MES Integration: Connecting ERP, LIMS, SCADA and Equipment"},"content":{"rendered":"<p><strong>Pharma MES integration connects production planning, manufacturing execution, laboratory results and equipment data through interfaces with clear owners.<\/strong> A reliable design starts by deciding which system owns each record and event, then defining what crosses the boundary, when it moves and how the plant handles a failed exchange.<\/p>\n<figure><img decoding=\"async\" src=\"https:\/\/accevo.com\/wp-content\/uploads\/2026\/10\/pharma-mes-integration-illustration.jpg\" alt=\"AI-generated illustration of pharmaceutical production equipment and an instrumented control cabinet in a clean manufacturing suite.\" title=\"\"><figcaption>Ilustracja wygenerowana przez sztuczn\u0105 inteligencj\u0119. Nie przedstawia obiektu nale\u017c\u0105cego do firmy Accevo ani do jej klienta.<\/figcaption><\/figure>\n<h2>Map system responsibilities before choosing interfaces<\/h2>\n<p>ISA-95 gives teams a common model for discussing information exchanged between enterprise planning and manufacturing operations. The ISA framework describes manufacturing operations management around Level 3 and business planning around Level 4. Use the model to clarify responsibilities, then map your actual applications and equipment to the work they perform.<\/p>\n<p>In a pharma MES architecture, the main systems may include ERP, MES, LIMS, SCADA, PLCs and production equipment. The exact boundary depends on the process, the installed systems and the site&#8217;s approved procedures. An MES interface does not automatically make the MES the owner of every data item or control action.<\/p>\n<figure><img decoding=\"async\" src=\"https:\/\/accevo.com\/wp-content\/uploads\/2026\/10\/pharma-mes-system-responsibilities.png\" alt=\"Illustrative map of ERP planning, MES execution and batch workflow, LIMS laboratory results, SCADA and PLC equipment signals, and equipment control.\" title=\"\"><figcaption>Illustrative system-responsibility map. Confirm roles and interface authority for the site and use case.<\/figcaption><\/figure>\n<h2>Define the information each system exchanges<\/h2>\n<ul>\n<li><strong>Od systemu ERP do MES:<\/strong> production order, product and material identifiers, planned quantity, schedule and order status where included in the agreed scope.<\/li>\n<li><strong>MES to ERP:<\/strong> execution status, completed quantity, material usage or other agreed production actuals. Define whether the MES or ERP closes each transaction.<\/li>\n<li><strong>MES and LIMS:<\/strong> sample requests, batch or order context, test status and results. State which system owns the test definition, result, review and any disposition.<\/li>\n<li><strong>MES and SCADA or equipment:<\/strong> selected states, counters, process values or alarms, and approved job references or instructions where the equipment architecture supports them.<\/li>\n<li><strong>SCADA and PLCs:<\/strong> supervisory and local-control exchanges defined by the automation design. Keep machine sequencing and safety functions under their designated control systems.<\/li>\n<\/ul>\n<p>For each flow, name the business event that starts it. \u201cSend batch details\u201d is too vague for an interface specification. State whether the trigger is order release, step start, sample collection, result approval or operation completion. Define the expected response and which record provides the final status.<\/p>\n<figure><img decoding=\"async\" src=\"https:\/\/accevo.com\/wp-content\/uploads\/2026\/10\/pharma-mes-integration-handoff-graph.png\" alt=\"Illustrative directed handoff graph for pharma MES integration: ERP orders and completion actuals, LIMS sample requests and results, and MES with SCADA and equipment references and events.\" title=\"\"><figcaption>Illustrative interface graph. Actual data ownership, directions and available interfaces vary by site.<\/figcaption><\/figure>\n<h2>Build an interface contract<\/h2>\n<p>Give every interface a short, reviewable contract with:<\/p>\n<ul>\n<li>source and receiving system, owner and business purpose;<\/li>\n<li>field names, definitions, units, allowed values and required identifiers;<\/li>\n<li>batch, order, product and material version rules;<\/li>\n<li>event trigger, timestamp source, time zone and expected response;<\/li>\n<li>duplicate, late, missing, rejected and out-of-sequence message behavior;<\/li>\n<li>recovery steps after a network or system outage; and<\/li>\n<li>reconciliation checks that show whether both systems agree.<\/li>\n<\/ul>\n<p>Identifiers deserve particular care. A batch number may be unique at one site but reused across sites; material codes may differ between ERP and MES; and a production order may span more than one unit operation. Agree on a stable mapping and keep the originating identifier with the receiving record.<\/p>\n<h2>Plan around exceptions, not just the happy path<\/h2>\n<p>Test an order that runs as planned, then test the cases that can interrupt it: a changed order, an unavailable material, a held batch, a rejected lab result, a disconnected machine or a message that arrives twice. Confirm what operators see and who decides whether to retry, correct or stop the workflow. Do not let a silent interface failure create a second source of truth in a spreadsheet or paper log.<\/p>\n<p>For equipment connectivity, inventory each machine&#8217;s available signals and interfaces before committing to a method. Some lines expose useful states through an existing control system; others need an OEM interface, gateway or separately engineered connection. Treat each machine as a discovery item rather than assuming one integration pattern covers the whole site.<\/p>\n<h2>Include quality and record scope in the design<\/h2>\n<p>When an electronic record supports a regulated activity, the site should identify the applicable record requirements and define how the interface preserves the record&#8217;s context and integrity. FDA&#8217;s <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/part-11-electronic-records-electronic-signatures-scope-and-application\" rel=\"nofollow noopener\" target=\"_blank\">Part 11 scope and application guidance<\/a> explains that Part 11 applies to electronic records maintained or submitted under applicable FDA record requirements. A connected MES architecture alone does not establish compliance; quality and system owners need to assess the intended use and applicable requirements.<\/p>\n<p>Test the interface requirements and data flow with production, quality, automation, laboratory, IT and system owners. Keep the approved mapping, test evidence, exceptions and change history with the site&#8217;s controlled project records. The validation approach should follow the site&#8217;s quality system and risk assessment.<\/p>\n<h2>Roll out one workflow, then expand<\/h2>\n<ol>\n<li>Choose one production workflow with a clear business problem and named owners.<\/li>\n<li>Map the order, batch, sample, equipment and completion records involved.<\/li>\n<li>Approve the source of truth, identifiers, interface contract and failure behavior.<\/li>\n<li>Test normal production, holds, corrections, duplicate messages and recovery.<\/li>\n<li>Reconcile records across ERP, MES, LIMS and control systems before expanding scope.<\/li>\n<\/ol>\n<p>For planning, read Accevo&#8217;s <a href=\"https:\/\/accevo.com\/pl\/blog\/pharma-mes-implementation-roadmap\/\">Plan wdro\u017cenia systemu MES w bran\u017cy farmaceutycznej<\/a>. To distinguish execution from the batch evidence it records, see <a href=\"https:\/\/accevo.com\/pl\/blog\/mes-kontra-ebr-pharma\/\">MES vs EBR in pharma<\/a>. Na stronie <a href=\"https:\/\/accevo.com\/pl\/blog\/linia-pakowania-z-integracja-systemow\/\">packaging-line MES integration guide<\/a> offers a parallel example of defining line data handoffs. Explore the <a href=\"https:\/\/accevo.com\/pl\/oprogramowanie-przemyslowe\/oprogramowanie-mes-pharma-przeznaczone-dla-branzy-farmaceutycznej\/\">Accevo pharma MES overview<\/a>, <a href=\"https:\/\/accevo.com\/pl\/glosariusz\/what-is-a-laboratory-information-management-system-lims\/\">LIMS definition<\/a> oraz <a href=\"https:\/\/accevo.com\/pl\/skalowalnosc-integracji\/\">integration and scalability page<\/a> for related context.<\/p>\n<h2>Pharma MES integration questions<\/h2>\n<h3>Does ERP or MES own the production order?<\/h3>\n<p>That depends on the site&#8217;s process and system design. Define which system creates, releases, changes and closes the order, and how the other system receives each status.<\/p>\n<h3>Should LIMS send results directly to MES?<\/h3>\n<p>Use a controlled interface when the workflow requires it and both systems support the exchange. Specify the sample and batch identifiers, result units, status, review state and error behavior. Keep the site&#8217;s approved result and disposition ownership explicit.<\/p>\n<h3>Should MES control pharmaceutical equipment?<\/h3>\n<p>MES may coordinate production work or provide approved job references where the architecture supports them. Local machine sequence and safety functions belong to the designated control systems. Document authority and test behavior with automation and quality owners.<\/p>\n<h3>Does connecting systems make them compliant?<\/h3>\n<p>No. The site must assess intended use, applicable record requirements, system controls and interface evidence under its quality processes. Integration is one part of the validated operating environment.<\/p>","protected":false},"excerpt":{"rendered":"<p>Plan pharma MES integration across ERP, LIMS, SCADA and equipment. Define system roles, interface data, exceptions and validation scope.<\/p>","protected":false},"author":2,"featured_media":40127,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wpai_generated_summary":"","footnotes":""},"categories":[30],"tags":[],"class_list":["post-40134","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/accevo.com\/pl\/wp-json\/wp\/v2\/posts\/40134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/accevo.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/accevo.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/accevo.com\/pl\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/accevo.com\/pl\/wp-json\/wp\/v2\/comments?post=40134"}],"version-history":[{"count":1,"href":"https:\/\/accevo.com\/pl\/wp-json\/wp\/v2\/posts\/40134\/revisions"}],"predecessor-version":[{"id":40135,"href":"https:\/\/accevo.com\/pl\/wp-json\/wp\/v2\/posts\/40134\/revisions\/40135"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/accevo.com\/pl\/wp-json\/wp\/v2\/media\/40127"}],"wp:attachment":[{"href":"https:\/\/accevo.com\/pl\/wp-json\/wp\/v2\/media?parent=40134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/accevo.com\/pl\/wp-json\/wp\/v2\/categories?post=40134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/accevo.com\/pl\/wp-json\/wp\/v2\/tags?post=40134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}